Classification Study Requests Clause Samples

The 'Classification Study Requests' clause defines the process by which one party may formally request a study to determine the appropriate classification of a product, service, or material under the agreement. Typically, this clause outlines the steps for submitting a request, the information required, and the timeline for conducting and responding to the study. For example, a party might request a classification study to clarify whether a product meets certain regulatory or contractual standards. The core function of this clause is to provide a structured mechanism for resolving uncertainties or disputes about classification, thereby reducing ambiguity and potential conflicts between the parties.
Classification Study Requests. In response to a written request from a department head, the Union, or an employee for a reclassification study, the Human Resources Department shall acknowledge receipt of said request and if possible indicate the general priority, if known, within thirty (30) calendar days of the date said request is received by the Human Resources Department. The Director of Human Resources or his designee will review the status of pending classification study requests with a staff member of Union upon request.
View SourceView Similar (14)
Classification Study Requests. The Human Resources Director or his/her designee will review the status of pending classification study requests with a staff member of the Union no more than once every ninety (90) calendar days. The decision of the Human Resources Director or his/her designee with respect to a classification study request shall not be subject to the grievance procedure. In response to a written request from the Union for a classification study on a form prescribed by the Human Resources Department, the Human Resources Department shall acknowledge receipt of said request within ten (10) working days, and if a study is justified, indicate the target date for completion of the study within thirty (30) working days of Human Resources acknowledgement notice. Class studies will be performed in a timely manner. If the request for a study is denied, the Personnel Analyst will provide justification for the denial. The Union may file a written appeal within ten (10) working days of receipt of denial with the assigned Personnel Analyst. If the request for a classification study was justified and the results of the study are not satisfactory to the Union, the Union may file a written appeal within ten (10) working days of receipt of results with the assigned Personnel Analyst. If the denial or results of a study are not satisfactorily resolved with the analyst, the Union may appeal, in writing, to the Department Human Resources Manager indicating the specific justification for appeal of the analyst’s decision, within ten (10) working days from receipt of the analyst’s decision. If the denial or results of a study are not satisfactorily resolved with the Department Human Resources Manager, the Union may appeal in writing to the Human Resources Director, or NMC CEO for employees of NMC, or his/her designee, within ten (10) working days from receipt of the Department Human Resources Manager decision, indicating the specific justification for appeal of the department’s decision. The decision of the Human Resources Director, or NMC CEO for employees of NMC, or his/her designee shall be final. At the request of the Union, the Human Resources Director, or NMC CEO for employees of NMC, or his/her designee will periodically review the status of pending classification studies requested by the Union, with a staff member of the Union. The results of classification studies requested by the Union will be sent to the Union prior to going to the Board. The provisions of this section shall not be su...
View SourceView Similar (11)
Classification Study Requests. In response to a written request from the Union for a reclassification study on a form prescribed by the Human Resources Division, the Human Resources Division shall acknowledge receipt of said request, and if a study is justified, indicate the target date for completion of the study within thirty (30) calendar days of receipt of said request. If the request for a study is denied or if the results of a completed study are not satisfactory to the Union, the Union may file a written appeal of the denial or the results with the assigned the Human Resources Division. Written appeals must be received by the Human Resources Division within ten (10) working days of receipt of the denial or results of the study. If the denial or results of a study are not satisfactorily resolved with the Human Resources Manager, the Union may appeal in writing to the CEO or designee indicating the specific justification for appeal of the Human Resources Manager's decision. Written appeals must be received by the CEO or designee within ten (10) working days of the Union's receipt of a response at the previous level. The decision of the CEO or designee shall be final. The CEO or designee will periodically review the status of pending classification studies requests with a staff member of the Union. This review will be scheduled to allow at least two (2) weeks between the time of review and the time of any action by the Executive Committee. The provisions of this section shall not be subject to the grievance procedure article of this MOU.
View SourceView Similar (6)
Classification Study Requests. ‌ In response to a written request from a Department Head, the Council, or an employee for a reclassification study, the Human Resources Department shall acknowledge receipt of said request, and if possible, indicate the general priority, if known, within thirty (30) calendar days of the date said request is received by the Human Resources Department. The Director of Human Resources or his/her designee will review the status of pending classification study requests with a staff member of Council upon request. Before the Board of Supervisors establishes the salary scale for any new class represented by the Council, the County shall meet and discuss the salary scale for the new classification with the Council.
View SourceView Similar (4)
Classification Study Requests. The Director of Human Resources or designee will review the status of pending classification studies with the Union during the Classification/Compensation and Compaction Committee meeting as stipulated in Article 7 Committees of this agreement. The decision of the Director of Human Resources or designee with respect to a classification study request shall not be subject to the grievance procedure. In response to a written request from the Union for a classification and/or compensation study on a form prescribed by the Human Resources Department, the Human Resources Department shall acknowledge receipt of said request within ten (10) working days, and if a study is justified, indicate the target date for completion of the study within thirty
View SourceView Similar (3)
Classification Study Requests. The Assistant CAO - Human Resources or his/her designee will review the status of pending classification studies requests with a staff member of the Union no more than once every ninety (90) calendar days. The decision of the Assistant CAO - Human Resources or his/her designee with respect to the request shall not be subject to the grievance procedure. In response to a written request from the Union for a classification study on a form prescribed by the Human Resources Division, the Human Resources Division shall acknowledge receipt of said request within ten (10) working days, and i f a study is justified, mdicate the target date for completion of the study within thirty (30) working days of Human Resources acknowledgement notice. Class studies will be performed in a timely manner. I f the request for a study is denied, the Personnel Analyst will provide justification for the denial. The Union may file a written appeal within ten (10) working days of receipt of denial with the assigned Personnel Analyst.
View SourceView Similar (2)
Classification Study Requests. In response to a written request from MCPA for a reclassification study on a form prescribed by the Human Resources Department, the Human Resources Department shall acknowledge receipt of said request, and if a study is justified, indicate the target date for completion of the study, within thirty (30) calendar days of receipt of said request. If the request for a study is denied or if the results of a completed study are not satisfactory to MCPA, MCPA may file a written appeal of the denial or the results with the assigned personnel analyst. The personnel analyst must receive written appeals within ten (10) working days of receipt of the denial or results of the study. If the denial or results of a study are not satisfactorily resolved with the analyst, MCPA may appeal in writing to the Human Resources Director indicating the specific justification for appeal. The Human Resources Director must receive written appeals within ten (10) working days of MCPA receipt of a response at the previous level. The decision of the Human Resources Director shall be final. The Human Resources Director or his/her designee will periodically review the status of pending classification studies requests with a staff member of MCPA. This review will be scheduled to allow at least two (2) weeks between the time of review and the time of any action by the Board of Supervisors. The provisions of this Article shall not be subject to the grievance procedure article of this Agreement.
View Source
Classification Study Requests. ‌ In response to a written request from a Department Head, the Union, or an employee for a reclassification study, the Human Resources Department shall acknowledge receipt of the request within fifteen (15) calendar days. The Human Resources Department shall provide notification to the requesting party within sixty (60) calendar days of receipt of the request if the request is accepted, rejected, or if more information is needed. When accepted, and if possible, Human Resources will indicate the general priority, if known, when notifying the requesting party of acceptance. The Human Resources Director, or designee, will review the status of pending classification study requests with a staff member of the Union upon request, but not more frequently than every three months.
View Source

Related to Classification Study Requests

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in ▇▇▇▇ rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • How to File an Appeal of a Prescription Drug Denial For denials of a prescription drug claim based on our determination that the service was not medically necessary or appropriate, or that the service was experimental or investigational, you may request an appeal without first submitting a request for reconsideration. You or your physician may file a written or verbal prescription drug appeal with our pharmacy benefits manager (PBM). The prescription drug appeal must be submitted to us within one hundred and eighty (180) calendar days of the initial determination letter. You will receive written notification of our determination within thirty (30) calendar days from the receipt of your appeal. Your appeal may require immediate action if a delay in treatment could seriously jeopardize your health or your ability to regain maximum function, or would cause you severe pain. To request an expedited appeal of a denial related to services that have not yet been rendered (a preauthorization review) or for on-going services (a concurrent review), you or your healthcare provider should call: • our Grievance and Appeals Unit; or • our pharmacy benefits manager for a prescription drug appeal. Please see Section 9 for contact information. You will be notified of our decision no later than seventy-two (72) hours after our receipt of the request. You may not request an expedited review of covered healthcare services already received.

  • Office of Inspector General Investigative Findings Expert Review In accordance with Senate Bill 799, Acts 2021, 87th Leg., R.S., if Texas Government Code, Section 531.102(m-1)(2) (eff. Apr. 1, 2025, Section 544.0106, pursuant to House Bill 4611, Acts 2023, 88th Leg., R.S.) is applicable to this Contract, Contractor affirms that it possesses the necessary occupational licenses and experience.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement or the Prospectus, or the results of which are referred to in the Registration Statement or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMA, Health Canada and other comparable regulatory agencies outside of the U.S. to which they are subject, including, without limitation, 21 C.F.R. Parts 50, 54, 56, 58, 312, and 812; the descriptions of the results of such studies, tests and trials contained in the Registration Statement or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Registration Statement or the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.